Canada’s early contributions and long-standing academic expertise in artificial intelligence are now generating growing funding for and revenue in AI in drug development, but the country’s AI-enabled drug development industry faces significant challenges in coming years, Dr. Ulrik Kristensen, PhD, founder and principal analyst at UK-based Emersion Insights, says in an op-ed.
Organization: AbCellera
Precision NanoSystems receives federal support to build $50 million biomanufacturing facility in Vancouver
New plant expected to produce 240 million vaccine doses every year starting in 2023.
The Short Report – May 27, 2020: DMZ and Ryerson Futures merge; Canadian psychedelic research gets boost; CFI launches $25-million competition; progress on a homegrown COVID-19 vaccine; and more
The Natural Sciences and Engineering Research Council has awarded $76 million for 128 new applied research projects at colleges, cégeps and polytechnics. Funded through the tri-agency College and Community Innovation Program and the College-Industry Innovation Fund from the Canada Foundation for Innovation, the investments will connect colleges with local companies, particularly small- and medium-sized enterprises, to collaborate on projects that further…
The Short Report, March 25, 2020: Tech CEOs implore Ottawa to protect their industry, the NGEN supercluster commits $50M to scaling up production of supplies to fight COVID-19, and more
The Canadian Institutes of Health Research launched a new COVID-19 funding opportunity for operating grants called the “COVID-19 Clinical Epidemiology Research Rapid Response.” The application deadline is this Friday, March 27, and successful applicants will be notified of the decision on April 1. The competition description emphasizes the viruses “many unknown epidemiological parameters, particularly with respect…
Ottawa moves with “unprecedented” speed to fast-track COVID-19 research
In collaborating with the WHO and other governments, Canada’s funding agencies have moved rapidly to channel more than $52 million in federal funding to rapid response research at Canadian universities.
Vancouver biotech firm AbCellera wins SIF research funding to fast-track antibody therapies against COVID-19
Vancouver-based biotech firm AbCellera, using its technology spun off research at University of British Columbia, is fast-tracking testing and clinical trials of therapeutic antibodies against COVID-19.